Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease
建立医疗之家,为患有镰状细胞病的青少年和成人提供循证护理
基本信息
- 批准号:10436589
- 负责人:
- 金额:$ 17.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-05 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute pain managementAddressAdherenceAdolescentAdoptionAdultAgeBenefits and RisksCaringChildChildhoodChronicClinical ManagementCommunitiesConsentConsolidated Framework for Implementation ResearchCountryDataDevelopmentDiagnosisDiseaseDissemination and ImplementationEducationEmergency Department PhysicianFDA approvedFacultyFocus GroupsFundingFutureGoalsGuidelinesHealth Care CostsHealthcare SystemsHematologyHomeIndividualInfant CareInterventionInterviewLettersLife ExpectancyLocationMedicalMedical centerModelingModernizationNational Heart, Lung, and Blood InstituteNeeds AssessmentNeighborhoodsNeonatal ScreeningOncologyOrganOutcomePainParticipantPatientsPenicillinsPhasePopulationPositioning AttributePractice GuidelinesPrimary Health CareProcessProviderRecording of previous eventsRegistriesResearchResearch Project GrantsRuralSickle CellSickle Cell AnemiaSiteStigmatizationSurveysTeenagersUnderinsuredUnderserved PopulationUninsuredUniversitiesbaseburden of illnesscare providerschronic painclinical carecohortcommunity involvementdesigndisease natural historydisease registryeducation planningeffective therapyeligible participantevidence baseexperiencehealth care settingshydroxyureaimplementation interventionimplementation scienceimprovedinterestmemberoutreach clinicsparticipant enrollmentpatient orientedpatient populationpatient registrypractice settingprophylacticrecruitresponsetreatment guidelines
项目摘要
PROJECT SUMMARY
Life expectancy for patients with sickle cell disease (SCD) has increased from teens to late
forties over the last 30 years. The increase in the number of adults with the disease has created
new unmet needs, due to the heavy disease burden and organ damage which increase with
age. This is confounded by the inability of the health care system to adequately meet the needs
of this population, and thus has resulted in disparities and increase in health care costs. This
project attempts to address these problems by creating medical homes and medical
neighborhoods in four different settings throughout rural Georgia, which has the fourth largest
population of patients with SCD in the country. This will be achieved by building on the GRU
Sickle Cell Center's experience in taking care of SCD patients through its outreach clinics, and
more recently through its partnership with primary care practices and Hematology/Oncology
practices at different locations in the state. In the first two years of the project (Phase I) a needs
assessment of patients, communities, and providers will be carried out and a Community
Advisory Council will be established. The results of this needs assessment will be used to
develop and implement interventions to establish medical homes and neighborhoods to improve
evidence-based care for SCD patients in Phase II.
项目摘要
镰状细胞疾病(SCD)患者的预期寿命已从青少年增加到晚期
过去30年中四十年代。疾病成年人的数量增加
由于疾病负担和器官损害的重大损害,新的未满足需求随着
年龄。这是由于医疗保健系统无法充分满足需求而感到困惑
在这个人群中,因此导致差异和医疗保健成本的增加。这
项目试图通过创建医疗家庭和医疗来解决这些问题
佐治亚州农村四种不同环境中的社区,该环境拥有第四大
该国SCD患者的人口。这将通过在GRU上建造来实现
镰状细胞中心通过其外展诊所照顾SCD患者的经验,
最近,通过与初级保健实践和血液学/肿瘤学的合作伙伴关系
在该州的不同地点进行练习。在项目的前两年(第一阶段)
将对患者,社区和提供者进行评估,并进行社区
咨询委员会将建立。这些需求评估的结果将用于
制定和实施干预措施以建立医疗家庭和社区以改进
II期SCD患者的循证护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert William Gibson其他文献
Robert William Gibson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert William Gibson', 18)}}的其他基金
Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease
建立医疗之家,为患有镰状细胞病的青少年和成人提供循证护理
- 批准号:
10005740 - 财政年份:2016
- 资助金额:
$ 17.66万 - 项目类别:
Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease
建立医疗之家,为患有镰状细胞病的青少年和成人提供循证护理
- 批准号:
10197195 - 财政年份:2016
- 资助金额:
$ 17.66万 - 项目类别:
Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease
建立医疗之家,为患有镰状细胞病的青少年和成人提供循证护理
- 批准号:
10440130 - 财政年份:2016
- 资助金额:
$ 17.66万 - 项目类别:
Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease
建立医疗之家,为患有镰状细胞病的青少年和成人提供循证护理
- 批准号:
10005725 - 财政年份:2016
- 资助金额:
$ 17.66万 - 项目类别:
Implementation of Medical Homes for Evidence Based Care of Adolescents and Adults with Sickle Cell Disease
建立医疗之家,为患有镰状细胞病的青少年和成人提供循证护理
- 批准号:
9180526 - 财政年份:2016
- 资助金额:
$ 17.66万 - 项目类别:
Mu Opioid Polymorphisms as Genetic Modifiers of Pain and Opioid Use in
Mu 阿片类药物多态性作为疼痛的基因修饰剂和阿片类药物的使用
- 批准号:
8410044 - 财政年份:2013
- 资助金额:
$ 17.66万 - 项目类别:
Mu Opioid Polymorphisms as Genetic Modifiers of Pain and Opioid Use in
Mu 阿片类药物多态性作为疼痛的基因修饰剂和阿片类药物的使用
- 批准号:
8374784 - 财政年份:2012
- 资助金额:
$ 17.66万 - 项目类别:
NCMHD Southeastern Exploratory Sickle Cell Center of Excellence
NCMHD 东南镰状细胞卓越研究中心
- 批准号:
8410040 - 财政年份:2009
- 资助金额:
$ 17.66万 - 项目类别:
NCMHD Southeastern Exploratory Sickle Cell Center of Excellence
NCMHD 东南镰状细胞卓越研究中心
- 批准号:
7849069 - 财政年份:2009
- 资助金额:
$ 17.66万 - 项目类别:
相似海外基金
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 17.66万 - 项目类别:
Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery (MIRHIQL)
为脊柱手术中长期使用阿片类药物的患者整合定制的术后阿片类药物逐渐减量和疼痛管理支持 (MIRHIQL)
- 批准号:
10722943 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
- 批准号:
10726834 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
The lipid hydrolase NAAA as a target for non-addictive analgesic medications
脂质水解酶 NAAA 作为非成瘾性镇痛药物的靶标
- 批准号:
10584428 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别:
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
- 批准号:
10584712 - 财政年份:2023
- 资助金额:
$ 17.66万 - 项目类别: